Patent details

EP2055313 Title: Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-CD20 antibody

Basic Information

Publication number:
EP2055313
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP090025040
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-CD20 antibody
French Title of Invention:
Traitment d'afféctions malignes hématologiques associées à des cellules tumorales en circulation au moyen d'un anticorps chimère anti-CD20
German Title of Invention:
Behandlung hämatologischer Bösartigkeiten assoziiert mit zirkulierenden Tumorzellen unter Verwendung chimärer anti-CD20 Antikörper
SPC Number:

Dates

Filing date:
09/11/1999
Grant date:
29/04/2015
EP Publication Date:
29/04/2015
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
06/05/2009
EP B1 Publication Date:
29/04/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
09/11/2019
Renunciation date:
Revocation date:
30/07/2019
Annulment date:

Owner

From:
13/07/2015
 
 

Name:
Biogen Inc.
Address:
225 Binney Street, Cambridge MA 02142, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
22/07/2015
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
Grillo-Lopez Antonio J.
Address:
United States (US)

2

Name:
White Christine A.
Address:
United States (US)

Priority

Priority Number:
107658
Priority Date:
09/11/1998
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 39/395;

Publication

European Patent Bulletin

Issue number:
202039
Publication date:
23/09/2020
Description:
Revocation of the European patent

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
05/11/2018
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
MDC (HENKEL PATENT)
Filing date Document type Number of pages